Multiple Myeloma Management vs SurvivorNet Uso & Estadísticas

Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
  • App Store de Apple
  • Gratis
  • Medicina

Clasificación de tiendas

- -

We believe far too many people still struggle to find information about treatments that can save their lives. SurvivorNet is closing this gap by creating a deep, video-based educational resource for patients featuring top physicians and researchers around the country. To create patient-focused educational content, the company is working with physicians at leading NCCN-designated cancer centers such as The National Cancer Institute, Dana-Farber, Memorial Sloan Kettering, Stanford, NYU, and M.D. Anderson.
  • App Store de Apple
  • Gratis
  • Salud y fitness

Clasificación de tiendas

- -

Multiple Myeloma Management frente a SurvivorNet: comparación de la clasificación

Comparar la tendencia de clasificación de Multiple Myeloma Management en los últimos 28 días con SurvivorNet

Rank

No hay datos disponibles

Comparación de las clasificaciones Multiple Myeloma Management frente a SurvivorNet por países

Comparar la tendencia de clasificación de Multiple Myeloma Management en los últimos 28 días con SurvivorNet

No hay datos para mostrar

Compara con cualquier sitio gracias a nuestra prueba gratuita

Empieza ya
Multiple Myeloma Management VS.
SurvivorNet

19iciembre d, 2024